Lawrence Corey, 2011-2014
Lawrence Corey, M.D., is president and director emeritus of Fred Hutch and currently a member of the Vaccine and Infectious Disease Division.
During his time at the helm of the Hutch, Corey launched initiatives to deepen scientific leadership and raise community awareness. He also worked to commercialize important technology, including helping to establish Juno Therapeutics, Inc., a new biotechnology company focused on bringing forward novel immunotherapies for cancer.
An internationally renowned expert in virology, immunology and vaccine development, Corey will continue to pursue research on herpes viruses, HIV and other viral infections, particularly those associated with cancer.